Cellivate Technologies develops engineered cell culture surfaces, consumables, and services for adherent cell growth and scale-up.
Cellivate Technologies has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.
Cellivate Technologies's investors include Antler, Venture Catalysts, Hatcher+, Animoca Brands, Brinc.
Cellivate Technologies is headquartered in Singapore, Singapore.
Cellivate Technologies develops engineered cell culture surfaces, consumables, and services for adherent cell growth and scale-up.
Cellivate Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellivate Technologies — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/cellivate-technologies. Accessed August 13, 2026.
VCBacked. (2024). Cellivate Technologies — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/cellivate-technologies
{{cite web |title=Cellivate Technologies — Funding & Investors |url=https://www.vcbacked.co/company/cellivate-technologies |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated